Genenta Science (GNTA) Institutional Ownership → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free GNTA Stock Alerts $2.59 -0.32 (-11.00%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Genenta Science (NASDAQ:GNTA)CurrentInstitutional OwnershipPercentage15.13%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$4.86MNumber ofInstitutional Sellers(last 12 months)0 Get GNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Genenta Science stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Genenta Science Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/24/2023Bank Julius Baer & Co. Ltd Zurich412,547$2.46M0.0%N/A2.264% 7/20/2023Bank Julius Baer & Co. Ltd Zurich412,547$2.46M0.0%N/A2.264% 2/13/2023Algebris UK Ltd45,000$242K0.1%N/A0.247% (Data available from 1/1/2016 forward) GNTA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GNTA shares? During the previous two years, the following institutional investors and hedge funds held shares of Genenta Science shares: Bank Julius Baer & Co. Ltd Zurich ($2.46M), Algebris UK Ltd ($242K).Learn more on GNTA's institutional investors. What percentage of Genenta Science stock is owned by institutional investors? 15.13% of Genenta Science stock is owned by institutional investors. Learn more on GNTA's institutional investor holdings. Which institutional investors have been buying Genenta Science stock? The following institutional investors have purchased Genenta Science stock in the last 24 months: Bank Julius Baer & Co. Ltd Zurich ($825.09K), and Algebris UK Ltd ($45K). How much institutional buying is happening at Genenta Science? Institutional investors have bought a total of 870,094 shares in the last 24 months. This purchase volume represents approximately $5.11M in transactions. Related Companies: Aligos Therapeutics Institutional Ownership Ikena Oncology Institutional Ownership Turnstone Biologics Institutional Ownership Cidara Therapeutics Institutional Ownership Instil Bio Institutional Ownership Elutia Institutional Ownership Semper Paratus Acquisition Institutional Ownership Dyadic International Institutional Ownership Cognition Therapeutics Institutional Ownership Gritstone bio Institutional Ownership This page (NASDAQ:GNTA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
